REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,749,211 | -24.4% | 414,055 | +112.4% | 0.02% | -31.8% |
| Q1 2023 | $6,278,083 | +176697.6% | 194,911 | +1.3% | 0.02% | +69.2% |
| Q4 2022 | $3,551 | -100.0% | 192,359 | -66.6% | 0.01% | -78.3% |
| Q3 2022 | $15,540,000 | +760.5% | 575,564 | +340.5% | 0.06% | +757.1% |
| Q2 2022 | $1,806,000 | -24.2% | 130,648 | +6.9% | 0.01% | 0.0% |
| Q1 2022 | $2,384,000 | +22.9% | 122,259 | +2.9% | 0.01% | +16.7% |
| Q4 2021 | $1,940,000 | -53.9% | 118,864 | -16.2% | 0.01% | -57.1% |
| Q2 2021 | $4,204,000 | +1637.2% | 141,825 | +766.1% | 0.01% | +600.0% |
| Q1 2020 | $242,000 | – | 16,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |